Local Coverage Decisions (LCDs)
- Nov. 2018: Noridian policy article "Use of Amniotic Membrane Derived Skin Substitutes”
- April 2018: WPS Wound Care Coding Companion for Wound Care L37228 (A55909)
- April 2018: WPS Future Local Coverage Determination - Wound Care (L37228)
- Sept. 2017: Novitas policy on Wound Care (L35125) - Final
- June 2017: DMEMAC Surgical Dressing LCD (L33831) and policy article – Final
- May 2017: DMEMACs LCD on Negative Pressure Wound Therapy Pumps (L33821) – Final
- March 2017: DMEMACs coverage updates with a revised NPWT policy that included the new NPUAP staging terminology. See LCD and policy article
- March 2017: Wisconsin Physicians Service Insurance Corporation (WPS) draft LCD on wound care (DL37228)
- Feb. 2017: Novitas Solutions draft LCD on treatment of varicose veins of the lower extremities (DL34924)
- Jan. 2017: First Coast Service Option draft LCD on wound care (DL37166)
- Jan. 2017: Novitas Solutions draft LCD on wound care (DL35125)
National Coverage Decisions (NCDs)
- May 2017: CMS Decision Memo Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)
- April 2017: CMS Decision Memo for Hyperbaric Oxygen (HBO) Therapy
CMS Regulations
Prospective Payment System (PPS) Regulations - proposed and final- November 2018: Final Rule - CY2019 Hospital Outpatient PPS and ASC Payment System (CMS fact sheet)
- November 2018: Final Rule - CY2019 Physician Fee Schedule and Quality Payment Program (CMS fact sheet)
- November 2018: Final Rule - CY2019 ESRD PPS / DMEPOS Competitive Bidding
- October 2018: Final Rule - CY2019 Home Health PPS (see accompanying CMS fact sheet)
- August 2018: Final Rule - CY2019 Hospital Inpatient PPS
- July 2018: Proposed updates to the Physician Fee Schedule
- July 2018: Proposed changes to DMEPOS payment policy & competitive bidding program, within the FY2019 End-Stage Renal Disease PPS
- May 2018: Proposed FY2019 PPS for Skilled Nursing Facilities (SNF)
- May 2018: Proposed FY2019 Revisions to Inpatient Hospital Prospective Payment System
Quality Payment Program and MACRA implementation regulations - proposed and final
- Nov. 2017: Quality Physician Payment Program
- June 2017: CMS CY 2018 Updates to MACRA’s Quality Payment Program and fact sheet
- Oct. 2016: Quality Payment Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models
- Dec. 2016: CMS updates to Patient Relationship Categories and Codes
- May 2016: CMS proposed Patient Relationship Categories and Codes
- May 2016: Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs) in Medicare Fee-for-Service (CMS-5517-P)
- Nov. 2016: Medicare Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models
Miscellaneous - CMS
- Oct. 2018: Changes to the Medicare Program Integrity Manual - Local Coverage Determinations (see accompanying MedLearn Matters)
- May 2018: Pre-Claim Review Demonstration for Home Health Services
- Sept. 2017: CMS Request for Information regarding the direction of the Center for Medicare and Medicaid Innovation Center (CMMI)
- July 2017: CMS Withdrawal of Part B Drug Payment Model Proposal
PDAC, MEDCAC, HCPCS Workgroups
- Nov. 2018: Changes to the HCPCS Coding Process for 2019
- Nov. 2018: CMS Level II HCPCS Coding Decisions for the 2018-2019 Coding Cycle
- Nov. 2017: CMS release of the 2018 Healthcare Common Procedure Coding System (HCPCS) code set
FDA
- Nov. 2017: Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff
- Aug. 2017: Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices – Guidance for industry and FDA staff
- Aug. 2016 - FDA’s General & Plastic Surgery Devices Panel public meeting notice regarding the classification of antimicrobial wound care products as Class II with special controls
- Dec. 2015: Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Draft Guidance for Industry and FDA Staff
- Dec. 2015: Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products: Draft Guidance for Industry and FDA Staff
Technology Assessments
- January 2018: ARHW draft Technology Assessment report Skin Substitutes for Treating Chronic Wounds
- April 2017: AHRQ technology assessment report Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD)
Medicare Payment Advisory Commission (MEDPAC)
- MedPAC reports to Congress
- MedPAC public meetings
Legislation
- Oct. 2017: H.R. 2445 DMEPOS Access & Transparency Act of 2017
- Aug. 2017: H.R. 3635 Local Coverage Determination Clarification Act of 2018
- March 2017: S.794 Local Coverage Determination Clarification Act of 2018
- March 2017: H.R.1542 - HELLPP Act
